← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tega Therapeutics, Inc.
La Jolla, CA
$2,584,350
Total funding
8
Grants
Funding over time
peak $500K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,584,350 · 8
By mechanism
R43$2,584,350 · 8
Investigators at Tega Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Title: New Clinical Biomarkers for GM1 Gamgliosidosis$500,000
R43 · FY2025 · NS
Title: Development and Validation of Therapy for GM1 Gangliosidosis$461,701
R43 · FY2023 · NS
Testing Novel Advancements to Recombinant Heparin Production$355,222
R43 · FY2024 · HL
Developing non-anticoagulant recombinant heparin for treating the COPD Pathogenic Triad$321,866
R43 · FY2022 · HL
Title: Intracerebroventricular sulfamidase delivery to the Brain$258,169
R43 · FY2020 · NS
Intranasal Sulfamidase Delivery to the Brain$237,138
R43 · FY2015 · NS
Intracerebroventricular alpha-N-acetylglucosaminidase Delivery to the Brain$225,254
R43 · FY2019 · NS
Intracerebroventricular Iduronidase Delivery to the Brain$225,000
R43 · FY2018 · NS